Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
TrueBlue to Announce Fourth Quarter and Full-Year 2024 Results
-
BARK Reports Third Quarter Fiscal Year 2025 Results
-
Sportsman’s Warehouse Announces Jeff Dunn as its new Chief Merchandising Officer
-
Groundbreaking Ceremony for State-of-the-Art 6.8mm Ammunition Facility at the Lake City Army Ammunition Plant
-
Wolverine Worldwide Declares Quarterly Dividend
-
Amundi US Declares Monthly Distributions for Six Pioneer Closed-End Funds
-
Green Brick Partners, Inc. Announces Dates For 8-K Filing and Earnings Call
-
AmTrust Announces Quarterly Cash Dividends on Preferred Stock
-
PennantPark Floating Rate Capital Ltd. Announces Monthly Distribution of $0.1025 per Share
-
QIAGEN delivers solid Q4 2024 growth ahead of outlook
-
Safehold Reports Fourth Quarter and Fiscal Year 2024 Results
-
ASGN Incorporated Reports Fourth Quarter and Full Year 2024 Results
-
Mister Car Wash to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
-
Etsy to Announce Fourth Quarter and Year End 2024 Financial Results on February 19, 2025
-
Renibus to Present at Oppenheimer's 35th Annual Healthcare Life Sciences Conference
-
GoodRx Appoints Christopher A. McGinnis as Chief Financial Officer
-
Nature’s Sunshine Appoints Katie A. May to Board of Directors
-
Terns Pharmaceuticals to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
LiveRamp Announces Results for Third Quarter FY25
-
AlTi Global, Inc. to Participate in Oppenheimer Emerging Growth Conference
-
Xperi to Release Fourth Quarter and Full Year 2024 Results on February 26, 2025
-
BKV Corporation Announces Fourth Quarter 2024 Earnings Call Details
-
ATIF Holdings Limited Announces Closing of $2.5 Million Registered Direct Offering and Private Placement
-
Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
-
Q2 2025 Results: Lesaka beats profitability guidance for Q2 2025, reaffirms FY2025 guidance and sets FY2026 profitability guidance
-
Quince Therapeutics to Present at Oppenheimer 35th Annual Healthcare Life Sciences Conference
-
Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
-
Tactile Medical to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 18, 2025
-
TEN Ltd. Declares Dividend on its Series E Cumulative Perpetual Preferred Shares
-
LPL Financial to present at the Bank of America Securities Financial Services Conference
-
Remitly to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025
-
Cytek Biosciences to Participate in Upcoming Investor Conferences
-
Paws of War Intensifies Efforts to Help Injured and Abandoned Animals in Ukraine Amid Ongoing Crisis
-
Lamborghini Westlake Sponsors Local Westlake High Graduate Mateo Siderman of TR3 Racing for 2025 Lamborghini Super Trofeo North American Season
-
AM Best Places Credit Ratings of Direct General Life Insurance Company Under Review With Developing Implications
-
Arm Holdings plc Reports Results for the Third Quarter of the Fiscal Year Ended 2025
-
NurExone Forms Exo-Top Inc. in the U.S. for Exosome Manufacture and Commercialization
-
Strategy Announces Fourth Quarter 2024 Financial Results; Holds 471,107 BTC
-
Central Garden & Pet Announces Q1 Fiscal 2025 Financial Results
-
Metsera Announces Closing of Initial Public Offering and Full Exercise and Closing of Underwriters’ Option to Purchase Additional Shares
-
Gaia Announces Proposed Underwritten Offering of Common Stock
-
PTC ANNOUNCES FIRST FISCAL QUARTER 2025 RESULTS
-
Cognizant Reports Fourth Quarter and Full-Year 2024 Results
-
FormFactor, Inc. Reports 2024 Fourth Quarter Results
-
Hologic Announces Financial Results for First Quarter of Fiscal 2025
-
Alpha and Omega Semiconductor Reports Financial Results for the Fiscal Second Quarter of 2025 Ended December 31, 2024
-
Skyworks Reports Q1 Fiscal 2025 Results
-
Blue Bird Reports Fiscal 2025 First Quarter Results; Beats First Quarter Guidance; Reaffirms 2025 Guidance and Long-Term Outlook
-
Ascendis Pharma to Report Full Year 2024 Financial Results and Provide Business Update on February 12, 2025
-
STANDEX ACQUIRES MCSTARLITE
